COMIRNATY ORIGINAL & OMICRON BA.4/BA.5
COMIRNATY ORIGINAL & OMICRON BA.4/BA.5
Discontinued
DIN Number
02531461
Drug Class
Human
Market Date
Oct 11, 2022
Company
HC
BioNTech Manufacturing GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02531461
AIG Number0264101001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BN01 COVID-19, RNA-BASED VACCINE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
FAMTOZINAMERANActive
Strength: 15 MCG / 0.3 ML
Monograph: FAMTOZINAMERAN
TOZINAMERANActive
Strength: 15 MCG / 0.3 ML
Monograph: TOZINAMERAN